Great Lakes Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,010
Closed -$289K 838
2025
Q4
$289K Buy
3,010
+65
+2% +$6.31K ﹤0.01% 702
2025
Q3
$280K Buy
2,945
+165
+6% +$15.2K ﹤0.01% 710
2025
Q2
$242K Sell
2,780
-714
-20% -$60.6K ﹤0.01% 746
2025
Q1
$314K Sell
3,494
-24,873
-88% -$2.23M ﹤0.01% 683
2024
Q4
$2.27M Sell
28,367
-2,501
-8% -$217K 0.02% 463
2024
Q3
$2.78M Buy
30,868
+1,942
+7% +$163K 0.02% 440
2024
Q2
$2.28M Sell
28,926
-13,727
-32% -$1.13M 0.02% 454
2024
Q1
$3.72M Sell
42,653
-4,935
-10% -$421K 0.03% 389
2023
Q4
$3.92M Sell
47,588
-76,593
-62% -$5.84M 0.04% 368
2023
Q3
$9.73M Sell
124,181
-20,735
-14% -$1.74M 0.09% 198
2023
Q2
$12.8M Buy
144,916
+95,900
+196% +$8.26M 0.13% 182
2023
Q1
$3.95M Buy
49,016
+24,167
+97% +$1.97M 0.04% 404
2022
Q4
$1.93M Buy
24,849
+813
+3% +$65.9K 0.11% 296
2022
Q3
$1.94M Buy
24,036
+696
+3% +$62.5K 0.04% 350
2022
Q2
$2.1M Buy
23,340
+1,878
+9% +$190K 0.04% 358
2022
Q1
$2.38M Buy
21,462
+3,907
+22% +$413K 0.04% 357
2021
Q4
$1.82M Sell
17,555
-188
-1% -$21.8K 0.03% 398
2021
Q3
$2.22M Sell
17,743
-49
-0.3% -$6.34K 0.03% 367
2021
Q2
$2.21M Sell
17,792
-8,676
-33% -$1.09M 0.03% 377
2021
Q1
$3.13M Buy
26,468
+4,312
+19% +$505K 0.05% 323
2020
Q4
$2.6M Buy
22,156
+414
+2% +$45.6K 0.05% 336
2020
Q3
$2.26M Buy
21,742
+5,225
+32% +$525K 0.05% 322
2020
Q2
$1.51M Sell
16,517
-1,368
-8% -$131K 0.04% 365
2020
Q1
$1.61M Sell
17,885
-2,713
-13% -$289K 0.05% 325
2019
Q4
$2.34M Sell
20,598
-40
-0.2% -$4.39K 0.05% 323
2019
Q3
$2.24M Buy
20,638
+316
+2% +$33K 0.05% 330
2019
Q2
$1.98M Sell
20,322
-2,785
-12% -$254K 0.04% 345
2019
Q1
$2.1M Sell
23,107
-33,774
-59% -$3.02M 0.05% 330
2018
Q4
$5.17M Buy
56,881
+45,726
+410% +$4.27M 0.12% 183
2018
Q3
$1.1M Buy
11,155
+825
+8% +$76.3K 0.02% 378
2018
Q2
$884K Buy
10,330
+935
+10% +$78.1K 0.02% 391
2018
Q1
$754K Sell
9,395
-761
-7% -$62.8K 0.02% 393
2017
Q4
$820K Sell
10,156
-210
-2% -$16.8K 0.02% 405
2017
Q3
$806K Sell
10,366
-2,676
-21% -$222K 0.02% 393
2017
Q2
$1.16M Buy
13,042
+2,556
+24% +$216K 0.03% 354
2017
Q1
$845K Buy
10,486
+632
+6% +$49.4K 0.02% 376
2016
Q4
$702K Sell
9,854
-20,872
-68% -$1.64M 0.02% 390
2016
Q3
$2.65M Sell
30,726
-5,835
-16% -$508K 0.07% 220
2016
Q2
$3.17M Buy
36,561
+13,463
+58% +$1.09M 0.09% 210
2016
Q1
$1.73M Buy
23,098
+19,470
+537% +$1.47M 0.05% 289
2015
Q4
$279K Sell
3,628
-20
-0.5% -$1.51K 0.01% 475
2015
Q3
$244K Buy
3,648
+277
+8% +$20.4K 0.01% 489
2015
Q2
$250K Buy
3,371
+645
+24% +$49.3K 0.01% 501
2015
Q1
$213K Buy
+2,726
New +$207K 0.01% 513
2013
Q4
Sell
-9,262
Closed -$493K 391
2013
Q3
$493K Buy
9,262
+97
+1% +$5.22K 0.02% 249
2013
Q2
$472K Buy
+9,165
New +$453K 0.02% 241

Other funds holding MDT

Great Lakes Advisors's MDT Position: Q1 2026 in Review

Great Lakes Advisors sold out of Medtronic (MDT) in Q1 2026, closing a stake of 3,010 shares — an estimated $289K sold.

Great Lakes Advisors first reported a position in MDT in Q2 2013 and held it in 46 quarters. The position peaked at $12.8M in Q2 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Great Lakes Advisors reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Great Lakes Advisors sold 3,010 Medtronic shares in Q1 2026, an estimated $289K.
  • Great Lakes Advisors first reported a position in Medtronic in Q2 2013 and held it in 46 quarters.
  • Great Lakes Advisors's Medtronic position peaked at $12.8M in Q2 2023.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Great Lakes Advisors's 13F filing for Q1 2026, filed 12 May 2026.